Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Hermes

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Urology|May 6, 2008
Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasionBarbara Hermes, Felix Spöler, Amjad Naami, et al.
Radiology and Oncology|November 25, 2021
Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient populationVlatko Potkrajcic, Frank Traub, Barbara Hermes, et al.
Cancers|April 17, 2020
MR Thermometry Data Correlate with Pathological Response for Soft Tissue Sarcoma of the Lower Extremity in a Single Center Analysis of Prospectively Registered PatientsMichaela Unsoeld, Ulf Lamprecht, Frank Traub, et al.
The American Journal of Pathology|August 26, 2003
Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosisKarin Hartmann, Metin Artuc, Stephan E Baldus, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 18, 2020
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)Isabelle Ray-Coquard, Helen Hatcher, Emmanuelle Bompas, et al.
Journal of Cancer Research and Clinical Oncology|February 16, 2022
MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumorsStefan Schönberger, Mahsa Mir Mohseni, Jörg Ellinger, et al.
JAMA Oncology|May 30, 2020
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-upHeikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2020
A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407Luis Paz-Ares, David Vicente, Ali Tafreshi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2019
Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung CancerJulien Mazieres, Dariusz Kowalski, Alexander Luft, et al.
The New England Journal of Medicine|October 4, 2018
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung CancerLuis Paz-Ares, Alexander Luft, David Vicente, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Urology|May 6, 2008
Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasionBarbara Hermes, Felix Spöler, Amjad Naami, et al.
Radiology and Oncology|November 25, 2021
Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient populationVlatko Potkrajcic, Frank Traub, Barbara Hermes, et al.
Cancers|April 17, 2020
MR Thermometry Data Correlate with Pathological Response for Soft Tissue Sarcoma of the Lower Extremity in a Single Center Analysis of Prospectively Registered PatientsMichaela Unsoeld, Ulf Lamprecht, Frank Traub, et al.
The American Journal of Pathology|August 26, 2003
Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosisKarin Hartmann, Metin Artuc, Stephan E Baldus, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 18, 2020
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)Isabelle Ray-Coquard, Helen Hatcher, Emmanuelle Bompas, et al.
Journal of Cancer Research and Clinical Oncology|February 16, 2022
MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumorsStefan Schönberger, Mahsa Mir Mohseni, Jörg Ellinger, et al.
JAMA Oncology|May 30, 2020
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-upHeikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2020
A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407Luis Paz-Ares, David Vicente, Ali Tafreshi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2019
Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung CancerJulien Mazieres, Dariusz Kowalski, Alexander Luft, et al.
The New England Journal of Medicine|October 4, 2018
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung CancerLuis Paz-Ares, Alexander Luft, David Vicente, et al.
Pageof 3